Publications

A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma

Cybersecurity in Science and Medicine: Threats and Challenges

Mol Carcinog | 2020 (PubMed) Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer

Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway

Human Mitotic Centromere-Associated Kinesin Is Targeted by MicroRNA 485-5p/181c and Prognosticates Poor Survivability of Breast Cancer

Overexpression of ASPM gene is associated with aggressiveness and poor outcome in bladder cancer

FDA Guidance for Next Generation Sequencing-based Testing: Balancing Regulation and Innovation in Precision Medicine

Benefits and Harms of the Centers for Medicare & Medicaid Services Ruling on Results From Genome Sequencing

Ribonucleotide reductase subunit M2B deficiency leads to mitochondrial permeability transition pore opening and is associated with aggressive clinicopathological manifestations of breast cancer

An integrated bioinformational analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer

A homozygous variant in RRM2B is associated with severe metabolic acidosis and early neonatal death

Novel common genetic susceptibility loci for colorectal cancer

Overexpression of Uridine-Cytidine Kinase 2 Correlates with Breast Cancer Progression and Poor Prognosis

Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers

Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker

Preclinical effects of CRLX101, and investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis

Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma